PLIANT THERAPEUTICS, INC. (PLRX) Operating cash flow 2019–2025
PLIANT THERAPEUTICS, INC. (PLRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$128.3MFY2025 · since FY2019: -$2.8M → -$128.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$128.3M | +17.5% |
| FY2024 | -$155.5M | -33.6% |
| FY2023 | -$116.4M | -23.0% |
| FY2022 | -$94.6M | -25.4% |
| FY2021 | -$75.4M | -102.4% |
| FY2020 | -$37.3M | -1255.3% |
| FY2019 | -$2.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PLRX financial trends
PLRX RevenuePLRX Net incomePLRX Net marginPLRX Gross profitPLRX Gross marginPLRX Operating incomePLRX Operating marginPLRX Free cash flowPLRX Capital expendituresPLRX Return on equityPLRX Stock buybacksPLRX Dividends paidPLRX Total assetsPLRX Total liabilitiesPLRX Shareholders’ equityPLRX overview →